Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Apolipoprotein E structure: insights into function.

Hatters DM, Peters-Libeu CA, Weisgraber KH.

Trends Biochem Sci. 2006 Aug;31(8):445-54. Epub 2006 Jul 3. Review.

PMID:
16820298
2.

Role of ApoE in conformation-prone diseases and atherosclerosis.

Dergunov AD.

Biochemistry (Mosc). 2006 Jul;71(7):707-12. Review.

PMID:
16903824
3.

The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.

Iurescia S, Fioretti D, Mangialasche F, Rinaldi M.

J Alzheimers Dis. 2010;21(1):35-48. doi: 10.3233/JAD-2010-100009. Review.

PMID:
20182014
4.
5.

The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.

Pham T, Kodvawala A, Hui DY.

Biochemistry. 2005 May 24;44(20):7577-82.

PMID:
15896001
6.

Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.

Morrow JA, Arnold KS, Weisgraber KH.

Protein Expr Purif. 1999 Jul;16(2):224-30.

PMID:
10419818
7.

Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.

Huang Y.

Curr Opin Lipidol. 2010 Aug;21(4):337-45. doi: 10.1097/MOL.0b013e32833af368. Review.

PMID:
20531185
8.

Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.

Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H.

J Biol Chem. 2005 Feb 18;280(7):5414-22. Epub 2004 Dec 6.

10.

Structural and functional variations in human apolipoprotein E3 and E4.

Chou CY, Jen WP, Hsieh YH, Shiao MS, Chang GG.

J Biol Chem. 2006 May 12;281(19):13333-44. Epub 2006 Mar 14.

11.

Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine.

Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH.

J Biol Chem. 2006 Jan 13;281(2):1073-9. Epub 2005 Nov 8.

12.

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Mahley RW, Huang Y.

Curr Opin Lipidol. 1999 Jun;10(3):207-17. Review.

PMID:
10431657
13.

NMR structure and dynamics of a receptor-active apolipoprotein E peptide.

Raussens V, Slupsky CM, Ryan RO, Sykes BD.

J Biol Chem. 2002 Aug 9;277(32):29172-80. Epub 2002 May 29.

14.

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.

Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA.

Science. 1991 Jun 28;252(5014):1817-22.

PMID:
2063194
15.

Structural analysis of lipoprotein E particles.

Schneeweis LA, Koppaka V, Lund-Katz S, Phillips MC, Axelsen PH.

Biochemistry. 2005 Sep 20;44(37):12525-34.

PMID:
16156664
16.

Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.

Fan J, Donkin J, Wellington C.

Biofactors. 2009 May-Jun;35(3):239-48. doi: 10.1002/biof.37. Review.

PMID:
19472365
17.

Interaction with amyloid beta peptide compromises the lipid binding function of apolipoprotein E.

Tamamizu-Kato S, Cohen JK, Drake CB, Kosaraju MG, Drury J, Narayanaswami V.

Biochemistry. 2008 May 6;47(18):5225-34. doi: 10.1021/bi702097s. Epub 2008 Apr 12.

PMID:
18407659
18.
19.

Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.

Saito H, Dhanasekaran P, Nguyen D, Holvoet P, Lund-Katz S, Phillips MC.

J Biol Chem. 2003 Jun 27;278(26):23227-32. Epub 2003 Apr 22.

20.

Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.

Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, Weisgraber KH.

Biochemistry. 2000 Sep 26;39(38):11657-66.

PMID:
10995233

Supplemental Content

Support Center